FBXO11

Overview

Somatic mutations in FBXO11 are common in BL1,2 and appear in a small number of DLBCLs.3 This gene has some recurrent sites of mutations (hot spots). Mutations lead to stabilization of BCL6, an important transcriptional repressor involved in lymphomagenesis.4 These mutations present a potential novel target for therapeutic intervention, particularly through strategies aimed at degrading BCL6 or inhibiting its function.4

History

Mutations in this gene were first described in BL in 2015 by Pighi et al4 and in DLBCL by Hübschmann et al.5

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% timeline title Publication timing 2012-11-11 : Richter : BL 2013-12-13 : Parry : MZL 2021-05-05 : Hübschmann : DLBCL

Relevance tier by entity

Entity Tier Description
MZL 2 relevance in MZL not firmly established1
BL 1 high-confidence BL generichterRecurrentMutationID32012a?
DLBCL 1 high-confidence DLBCL genehubschmannMutationalMechanismsShaping2021b?

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
BL GAMBL genomes+capture 23.79
BL Thomas cohort 21.60
BL Panea cohort 15.80
DLBCL GAMBL genomes 3.82
DLBCL Schmitz cohort 2.13
DLBCL Reddy cohort 2.10
DLBCL Chapuy cohort 2.56

Mutation pattern and selective pressure estimates

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
BL No Yes 14.801 114.063
DLBCL No Yes 2.464 39.449
FL No No 8.837 0.000

FBXO11 hot spots

Chromosome Coordinate Mutation HGVSp
chr2 48040426 T>A N725I
chr2 48040427 T>C N725D
chr2 48040427 T>G N725H
chr2 48040427 T>A N725Y
chr2 48040488 TA>GC I704S
chr2 48040489 A>C I704R
chr2 48040495 T>A N702I
chr2 48040495 T>C N702S
chr2 48040496 T>C N702D
chr2 48040496 T>A N702Y
chr2 48040500 T>A E700D
chr2 48040500 T>G E700D
chr2 48040501 T>A E700V
chr2 48040510 C>T G697D
chr2 48040511 C>G G697R

View coding variants in ProteinPaint hg19 or hg38

View all variants in GenomePaint hg19 or hg38

FBXO11 Expression

References

1.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S, Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier DG, Strefford JC. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One. 2013;8(12):e83244. PMCID: PMC3862727

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.